Home Page

The AIM-Bio Program

The Accelerated Innovation in Biomanufacturing Program, AIM-Bio, brings together two academic universities, NC State and the Technical University of Denmark (DTU), with complementary areas of expertise to create an international collaboration to drive innovation in research and education in manufacturing biopharmaceuticals. Funded by the Novo Nordisk Foundation, this five-year $27 million program will support the biopharmaceutical industry in both Denmark and the United States. The establishment of AIM-Bio will enhance educational, research and lifelong learning at both universities by:

  • Establishing a world-class research and development program
  • Expanding professional development programs
  • Facilitating international collaboration and exchange

AIM-Bio will benefit society by developing new technologies to reduce the cost and increase the effectiveness, safety and accessibility of new biopharmaceutical products. The program will also establish a lasting bond for international collaboration between NC State University and the Technical University of Denmark.

We invite you to explore the AIM-Bio website to learn more about the program and opportunities for students, academic researchers and industry professionals to participate in research, professional development courses, networking and much more.

NC State University and the Technical University of Denmark (DTU) are embarking on a 5-year program to advance biomanufacturing by collaborating on the AIM-Bio Program.

AIM-Bio Program Overview

Funded by a $27 million grant from the Novo Nordisk Foundation, the Accelerated Innovation in Manufacturing Biologics (AIM–Bio) project brings together two leading academic institutions, NC State University and the Technical University of Denmark. With complementary areas of experience and expertise, these two universities are creating an international collaborative enterprise engaged in education, lifelong learning, and process research and development in biomanufacturing science and technology. To address the future needs of the biopharmaceutical industry, BTEC, several departments at NC State, and the Technical University of Denmark (DTU) are carrying out this five-year project—from 2020 through 2025—to establish a world-class program in bioprocess research and development and workforce training that focuses on products and technologies critical to the future of biopharmaceutical manufacturing.